Value of LDH in Lymphoproliferative disorders

Document Type : Original Article

Authors

1 clinical pathology, faculty of medicine , minia univesity, Egypt

2 Department of clinical pathology, faculty of medicine, Minia university, Egypt

3 clinical pathology , faculty of medicine , minia university

4 clinical pathology,faculty of medicine ,Minia university

Abstract

Both the lymphatic tissues (as in lymphoma) & the bone marrow (as in leukaemia & myeloma) may be the site of lymphoproliferative diseases. Depending on the type & other personal circumstances, the course of the disease & its treatment can differ significantly. Subjects & methods the research carried out on60 patients, divided into3 groups, group I: 20 ALL patients, group II: 20 CLL patients and 20 NHL patients. Each patient was subjected to complete history taking, clinical examination, laboratory investigations in the form of routine investigations; CBC, LDH. Bone marrow aspiration, Immunophenotyping on bone marrow samples defined by Flowcytometer for routine panel of B cell lymphoid disorder. Results: significant statistically (p-value = 0.008) Age & LDH have a negative connection (r = - 0.59). Significant statistically high (p-value < 0.001) Correlation among lymph percentage & LDH is negative (r = - 0.74). Positive association (r = 0.58), statistically significant (p-value = 0.008) among lymph & LDH (abs). Positive correlation (r = 0.67), statistically significant (p-value = 0.002) among peripheral blast & LDH. Following therapy, there had been a positive correlation (r = 0.51) among peripheral blast & LDH that had been statistically significant (p-value = 0.024). Conclusion: LDH level act as valuable markers for managing lymphoprolieferative disorder. Its clinical applications can guide treatment strategies for this disease.

Keywords

Main Subjects

Minia Journal of Medical Research

Articles in Press, Accepted Manuscript
Available Online from 12 March 2024

Files

Share

How to cite

Statistics